A Phase 4 interventional study of Ropivacaine in Total Knee Arthroplasty and Pain, sponsored by Kreiskrankenhaus Dormagen. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-03-31.
Sponsored by Kreiskrankenhaus Dormagen · Phase 4, Interventional, and Treatment
The role of a sciatic block in addition to a femoral block remains controversial. The study addresses this topic by comparing a continuous block versus an injection on demand.
Kreiskrankenhaus Dormagen is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
injection of ropivacaine on demand
Drug: Ropivacaine
continuous ropivacaine infusion
Drug: Ropivacaine
pain score (VRS)
Time frame: 4 days
frequency of injections into the sciatic catheter
Time frame: 4 days
This study is completed, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kreiskrankenhaus Dormagen